$68.49
-1.04 (-1.50%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+11.37%
YTD
-13.40%
Open$69.84
Previous Close$69.53
Day High$69.84
Day Low$67.16
52W High$99.50
52W Low$40.00
Volume—
Avg Volume535.6K
Market Cap2.66B
P/E Ratio—
EPS$-6.57
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$78.91
Below
SMA 200
$68.08
Above
RSI (14)
34.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
-67.2% upside
Current
$68.49
$68.49
Target
$22.47
$22.47
$15.33
$22.47 avg
$35.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.46B | 1.47B | 1.18B |
| Net Income | -261,677,643 | -297,076,371 | -250,070,353 |
| Profit Margin | -18.0% | -20.2% | -21.1% |
| EBITDA | -537,620,569 | -578,764,523 | -403,482,661 |
| Free Cash Flow | -321,004,356 | -279,609,663 | -183,137,834 |
| Rev Growth | +12.9% | +6.2% | -8.5% |
| Debt/Equity | 0.11 | 0.12 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |